A

Apellis Pharmaceuticals
D

APLS

30.390
USD
0.29
(0.96%)
مغلق
حجم التداول
45,120
الربح لكل سهم
-1
العائد الربحي
-
P/E
-15
حجم السوق
3,780,303,787
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ABUS
    0.02000
    (0.63%)
    3.22000 USD
    AMGN
    AMGN
    -1.26
    (-0.46%)
    273.59 USD
    A
    ANAB
    -0.750
    (-4.44%)
    16.130 USD
    A
    ARWR
    -0.050
    (-0.25%)
    19.710 USD
    BIIB
    BIIB
    1.810
    (1.28%)
    142.750 USD
    BMY
    BMY
    0.025
    (0.04%)
    57.075 USD
    C
    CRBP
    -0.620
    (-5.18%)
    11.350 USD
    E
    EXEL
    -3.560
    (-9.77%)
    32.880 USD
    GE
    GE
    0.700
    (0.37%)
    188.300 USD
    GSK
    GSK
    -0.340
    (-1.01%)
    33.440 USD
    I
    INCY
    -1.050
    (-1.43%)
    72.420 USD
    المزيد
الأخبار
المقالات

العنوان: Apellis Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.